TEVA PHARMACEUTICAL INDUSTRIES LIMITED Increase (Decrease) in Inventories
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Increase (Decrease) in Inventories of -$59.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for the quarter ending 2026-06-30 was -$59.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for the quarter ending 2026-03-31 was -$93.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for the quarter ending 2025-06-30 was -$61.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for the quarter ending 2025-03-31 was -$120.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for fiscal 2025 was $152.00M, a 8.43% decline from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for fiscal 2024 was $166.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for fiscal 2023 was -$147.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED increase (decrease) in inventories for fiscal 2022 was -$163.00M, a 142.89% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|
| 2026-06-30 | -$59.00M 10-Q · filed 2026-07-29 | -$152.00M 10-Q · filed 2026-07-29 | ||
| 2026-03-31 | -$93.00M 10-Q · filed 2026-04-29 | |||
| 2025-12-31 | $152.00M 10-K · filed 2026-02-03 | |||
| 2025-06-30 | -$61.00M 10-Q · filed 2026-07-29 | -$181.00M 10-Q · filed 2026-07-29 | ||
| 2025-03-31 | -$120.00M 10-Q · filed 2026-04-29 | |||
| 2024-12-31 | $166.00M 10-K · filed 2026-02-03 | |||
| 2023-12-31 | -$147.00M 10-K · filed 2026-02-03 | |||
| 2022-12-31 | -$163.00M 10-K · filed 2025-02-05 | |||
| 2021-12-31 | $380.00M 10-K · filed 2024-02-12 | |||
| 2020-12-31 | $41.00M 10-K · filed 2023-02-10 | |||
| 2019-12-31 | $271.00M 10-K · filed 2022-02-09 | |||
| 2018-12-31 | $26.00M 10-K · filed 2021-02-10 | |||
| 2017-12-31 | $199.00M 10-K · filed 2020-02-21 | |||
| 2016-12-31 | $370.00M 10-K · filed 2019-02-19 | |||
| 2015-12-31 | $129.00M 10-K · filed 2018-02-12 | |||
| 2014-12-31 | $230.00M 20-F · filed 2017-02-15 | |||
| 2013-12-31 | $399.00M 20-F · filed 2016-02-11 | |||
| 2012-12-31 | -$511.00M 20-F · filed 2015-02-09 | |||
| 2011-12-31 | -$762.00M 20-F · filed 2014-02-10 | |||
| 2010-12-31 | -$124.00M 20-F · filed 2013-02-12 | -$16.00M 20-F · filed 2011-02-15 | ||
| 2009-12-31 | -$139.00M 20-F · filed 2012-02-17 | $163.00M 20-F · filed 2010-02-22 | ||
| 2008-12-31 | -$548.00M 20-F · filed 2011-02-15 | |||
| 2007-12-31 | -$421.00M 20-F · filed 2010-02-22 |